Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis-Reference-Cited by-全球学者库

Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis

Published:2015-11 Issue:11 Volume:46 Page:1685-1693
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Adachi Koko,Miki Yasuhiro,Saito Ryoko,Hata Shuko,Yamauchi Masanori,Mikami Yoshiki,Okada Yoshinori,Seyama Kuniaki,Kondo Takashi,Sasano Hironobu

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. Lymphangioleiomyomatosis: a wolf in sheep's clothing;Henske;J Clin Invest,2012

2. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM);Hayashi;Hum Pathol,1997

3. Lymphangioleiomyomatosis: current and future;Mavroudi;J Thorac Dis,2013

4. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status;Usuki;Arch Pathol Lab Med,1998

5. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways;Yu;Am J Physiol Lung Cell Mol Physiol,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors;Pathology - Research and Practice;2022-02

2. mTOR in Lung Neoplasms;Pathology & Oncology Research;2020-01

3. Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery;Frontiers in Pharmacology;2018-09-19

4. In situ analysis of mTORC1/2 and cellular metabolism–related proteins in human Lymphangioleiomyomatosis;Human Pathology;2018-09

5. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis;Annals of the American Thoracic Society;2017-06